FDA appropriation stalls
This article was originally published in The Tan Sheet
The House Appropriations Committee postpones a markup of fiscal 2011 agriculture funding legislation, leaving FDA funding in limbo. The House adjourned for August recess without taking action, leaving fiscal 2011 funding levels undetermined until Congress returns the week of Sept. 13. With all House members and some of the Senate soon to focus on elections, chances are growing for an omnibus bill or continuing resolution to fund federal agencies at the start of the next fiscal year (1"The Tan Sheet" July 26, 2010)
You may also be interested in...
FDA's fiscal 2011 funding is not the only decision Congress has yet to make - lawmakers likely will face passing either an omnibus spending bill or a continuing resolution to keep the federal government operating past the end of the current fiscal year
Pharmacist groups’ representatives, in meeting with FDA officials, reiterate argument for greater role in access to OTCs through “additional conditions for nonprescription use.” Group not at meeting, American Society of Health-System Pharmacists, suggests “intermediate approach to nonprescription status.”
PhRMA captures tone of its comments saying “proposed rule might play an important role” in making more drugs available OTC. AAM also references gauntlet, saying proposed pathway “would, in theory, broaden the types of nonprescription drugs available to consumers.” CHPA discusses same concerns as well as additional questions for FDA.